Welcome to our dedicated page for Enova Intl SEC filings (Ticker: ENVA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how Enova International funds high-velocity online loans or how rising delinquency rates impact margins often requires piecing together hundreds of pages across multiple forms. From securitization footnotes to state-specific lending caps, the disclosures can be daunting. If you’ve ever searched for “Enova International insider trading Form 4 transactions” or “Enova International quarterly earnings report 10-Q filing,” you know the challenge: the data exists, but it’s scattered.
Stock Titan solves that problem. Our AI-powered engine delivers “Enova International SEC filings explained simply,” turning raw documents into clear insights. Need “Enova International Form 4 insider transactions real-time” alerts? We surface them the moment they hit EDGAR and highlight which executive bought or sold. Want an “Enova International annual report 10-K simplified” walkthrough that pinpoints credit loss trends, funding costs, and regulatory risks? One click. Our coverage spans every filing type—10-Q, 8-K, DEF 14A, S-3—plus redlined comparisons and keyword search, so “understanding Enova International SEC documents with AI” becomes part of your daily workflow.
The platform connects filing types to what matters for a consumer-lending fintech. The 10-Q reveals net charge-offs; we transform that into a quarter-over-quarter chart for “Enova International earnings report filing analysis.” The proxy shows “Enova International proxy statement executive compensation,” including pay metrics tied to loan performance. Form 4 feeds flag “Enova International executive stock transactions Form 4,” letting you monitor insider sentiment before headlines move the stock. Even sudden disclosures are covered: “Enova International 8-K material events explained” highlights funding facility amendments or regulator inquiries within minutes. With real-time updates, AI summaries, and expert commentary, you can act on complete information instead of searching for it.
Enova International (ENVA) reported a proposed insider sale of 17,000 common shares, with an aggregate market value of $1,849,549. The shares were acquired and paid for by the seller on 08/12/2025 through a stock option exercise, with payment made in cash. The intended sale is to be executed the same day through Morgan Stanley Smith Barney LLC on the NYSE. The filing lists 25,012,613 shares outstanding for the issuer and shows no sales in the past three months by the selling person. The notice includes the seller's representation that they do not possess undisclosed material information. Several filer identification fields (CIK and filer name) are left blank in this document.
Form 4 filed for Enova International (ENVA) reports a new equity award to CEO & Director David Fisher. On 08/06/2025 Fisher received a non-qualified stock option covering 22,401 common shares at an exercise price of $103.92. The option carries a tandem limited stock appreciation right that can be exercised only within 30 days following a defined Change-in-Control event.
Vesting: the option vests in three equal one-third tranches on Aug 6, 2026 / 2027 / 2028, contingent on continued employment. It expires on 08/06/2032. Following the grant, Fisher now beneficially owns 22,401 derivative securities; no purchases or sales of common shares were disclosed.
The transaction appears to be routine executive compensation rather than an opportunistic trade, modestly strengthening alignment between management and shareholders without creating immediate dilution or signaling directional sentiment.
Enova International, Inc. (NYSE: ENVA) – Form 144 notice
Insider James Lee intends to sell up to 478 common shares through Morgan Stanley Smith Barney, with an estimated aggregate value of $50,484. The planned trade may occur on or after 29 Jul 2025 on the NYSE. Relative to the 25.0 million shares outstanding, the sale equals roughly 0.002 %, indicating a de-minimis transaction. The shares originate from restricted-stock grants received on 9 and 11 Feb 2024 (359 and 119 shares). Lee previously sold 550 shares on 2 May 2025 for $52,109.
The filing is procedural under Rule 144 and does not disclose any operational or financial developments. Given the very small size, it is unlikely to influence ENVA’s capital structure, liquidity, or share-price dynamics.
FAQ
What is the current stock price of Enova Intl (ENVA)?
What is the market cap of Enova Intl (ENVA)?
